Who owns ACUMEN PHARMACEUTICALS INC?
- Ticker: ABOS
- CUSIP Number: 00509g209
Tip: Access positions for across all investors
Analyze quarterly positions in Acumen Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acumen Pharmaceuticals stock
Who bought or sold ACUMEN PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 21M | $50M | 41% | Mar 2026 |
|
| Sands Capital Ventures | 3.7M | $8.8M | 9% | Mar 2026 |
|
| Alyeska Investment Group | 2.5M | $5.8M | 161% | Mar 2026 |
|
| Franklin Resources | 2.3M | $5.4M | 0% | Mar 2026 |
|
| ADAR1 Capital Management | 2.2M | $5.1M | 142% | Mar 2026 |
|
| FMR | 2.0M | $4.3M | 0% | Dec 2025 |
|
| Vanguard Group | 1.7M | $3.5M | 0% | Dec 2025 |
|
| Knollwood Investment Advisory | 1.6M | $3.8M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 1.5M | $3.6M | 100% | Mar 2026 |
|
| Ikarian Capital | 1.1M | $2.5M | 314% | Mar 2026 |
|
| Hudson Bay Capital Management | 969k | $2.3M | 34% | Mar 2026 |
|
| Laurion Capital Management | 867k | $1.8M | 0% | Dec 2025 |
|
| Pathstone Holdings | 859k | $2.0M | 0% | Mar 2026 |
|
| SG Americas Securities | 719k | $1.7M | 79% | Mar 2026 |
|
| Millennium Management | 660k | $1.6M | 13% | Mar 2026 |
|
| Two Sigma Investments | 531k | $1.3M | 271% | Mar 2026 |
|
| Renaissance Technologies | 423k | $893k | -28% | Dec 2025 |
|
| Geode Capital Management | 416k | $983k | 1% | Mar 2026 |
|
| Susquehanna International | 373k | $787k | 74% | Dec 2025 |
|
| Bank of America Corporation | 320k | $756k | 100% | Mar 2026 |
|
| Boothbay Fund Management | 273k | $644k | 590% | Mar 2026 |
|
| Goldman Sachs Group | 207k | $488k | 75% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 199k | $470k | 100% | Mar 2026 |
|
| Acadian Asset Management | 186k | $435k | 22% | Mar 2026 |
|
| BlackRock | 178k | $421k | 5% | Mar 2026 |
|
| Bridgeway Capital Management | 170k | $359k | -11% | Dec 2025 |
|
| Morgan Stanley | 145k | $341k | -13% | Mar 2026 |
|
| Jane Street | 132k | $312k | -7% | Mar 2026 |
|
| Dimensional Fund Advisors | 120k | $283k | 144% | Mar 2026 |
|
| State Street Corporation | 100k | $211k | -6% | Dec 2025 |
|
| Catalyst Financial Partners | 90k | $212k | 0% | Mar 2026 |
|
| PFG Investments | 81k | $191k | 326% | Mar 2026 |
|
| Northern Trust | 75k | $159k | 16% | Dec 2025 |
|
| Point72 Asset Management | 67k | $159k | 85% | Mar 2026 |
|
| Prospera Financial Services | 50k | $118k | 0% | Mar 2026 |
|
| XTX Topco | 50k | $105k | 100% | Dec 2025 |
|
| Quadrature Capital | 49k | $104k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 48k | $101k | 46% | Dec 2025 |
|
| Catalyst Funds Management Pty | 46k | $108k | 54% | Mar 2026 |
|
| UBS Group | 37k | $87k | 72% | Mar 2026 |
|
| Rangeley Capital | 35k | $83k | 100% | Mar 2026 |
|
| Intrepid Financial Planning Group | 30k | $71k | 0% | Mar 2026 |
|
| Barclays | 30k | $63k | 0% | Dec 2025 |
|
| OMERS Administration Corporation | 29k | $68k | 27% | Mar 2026 |
|
| Axq Capital | 29k | $67k | 100% | Mar 2026 |
|
| Marshall Wace | 21k | $44k | 100% | Dec 2025 |
|
| Independent Advisor Alliance | 19k | $45k | 0% | Mar 2026 |
|
| Pinnacle Wealth Management Advisory | 18k | $43k | 0% | Mar 2026 |
|
| Gail Mannix | 18k | $43k | 0% | Mar 2026 |
|
| Clune & Associates | 17k | $39k | 0% | Mar 2026 |
|
| Brevan Howard Capital Management | 15k | $36k | 100% | Mar 2026 |
|
| Squarepoint Ops | 15k | $35k | 100% | Mar 2026 |
|
| Hrt Financial | 13k | $31k | 100% | Mar 2026 |
|
| Jacobs Levy Equity Management | 13k | $31k | 100% | Mar 2026 |
|
| Citadel Advisors | 12k | $28k | -97% | Mar 2026 |
|
| Sei Investments | 12k | $27k | 100% | Mar 2026 |
|
| Mesirow Financial Investment Management International Equity | 11k | $27k | 100% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 11k | $27k | 100% | Mar 2026 |
|
| Virtu Financial | 11k | $23k | 100% | Dec 2025 |
|
| Integrated Wealth Concepts | 10k | $24k | 100% | Mar 2026 |
|
| Wells Fargo & Company | 10k | $24k | 42% | Mar 2026 |
|
| Royal Bank of Canada | 7.1k | $17k | 533% | Mar 2026 |
|
| Advisor Group Holdings | 6.9k | $15k | -6% | Dec 2025 |
|
| Vanguard Global Advisers | 6.7k | $16k | 100% | Mar 2026 |
|
| Citigroup | 4.5k | $11k | 100% | Mar 2026 |
|
| Tower Research Capital | 4.5k | $9.4k | 100% | Dec 2025 |
|
| Larson Financial Group | 4.3k | $9.2k | 9% | Dec 2025 |
|
| Pnc Financial Services | 3.1k | $7.3k | 0% | Mar 2026 |
|
| Rockefeller Capital Management | 3.0k | $7.1k | 0% | Mar 2026 |
|
| TFC Financial Management | 2.5k | $5.9k | 0% | Mar 2026 |
|
| Group One Trading | 1.5k | $3.5k | -69% | Mar 2026 |
|
| NISA Investment Advisors | 1.2k | $2.9k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 1.2k | $2.9k | -1% | Mar 2026 |
|
| EverSource Wealth Advisors | 407.00 | $961.008400 | 0% | Mar 2026 |
|
| SBI Securities | 303.00 | $714.989100 | -6% | Mar 2026 |
|
| Farther Finance Advisors | 200.00 | $510.000000 | 0% | Mar 2026 |
|
| NBT Bank | 200.00 | $472.000000 | 9900% | Mar 2026 |
|
| CWM | 147.00 | $0 | -80% | Dec 2025 |
|
| Hartland & Co | 60.00 | $142.002000 | 0% | Mar 2026 |
|
| SRS Capital Advisors | 26.00 | $61.001200 | 0% | Mar 2026 |
|
| Optiver Holding B.V. | 5.00 | $12.000000 | 0% | Mar 2026 |
|
Who sold out of Acumen Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Advisers | Dec 2025 | 422k | $890k |
| Nine Masts Capital | Dec 2025 | 11k | $22k |
| Jpmorgan Chase & Co | Sep 2025 | 3.0k | $5.3k |
| Advisory Services Network | Sep 2025 | 1.1k | $1.9k |
| Flagship Harbor Advisors | Dec 2025 | 350.00 | $738.990000 |